Computer-aided detection systems (CADe) are transforming adenoma detection and enhancing colonoscopy quality. Dr. Peter Buch sits down with Dr. Charles Kahi to unpack the latest American Gastroenterological Association (AGA) guideline, evidence from randomized controlled trials, and the practical implications of integrating AI tools into clinical practice. Dr. Kahi is a Professor of Medicine at Indiana University School of Medicine, and he helped develop the AGA Living Clinical Practice Guideline on Computer-Aided Detection-Assisted Colonoscopy, which was published in Gastroenterology in 2025.
Author: Abhay Panchal
With gastroenterologists in short supply, nurse practitioners and physician assistants are increasingly covering clinics and providing front-line GI care. Yet most receive little formal specialty training, forcing many to learn on the job while juggling mounting administrative tasks. Experts warn this lack of structure, combined with rising prior-authorization and EMR burdens, is fueling burnout—particularly among mid-career APPs.
Oath Surgical has raised $24 million in Series A funding to expand its nationwide network of surgeon-owned, tech-driven ambulatory surgery centers and further develop OathOS, an AI platform designed to automate operating room workflows. The Portland-based company, founded by Dr. Oliver Keown, reports up to 80% cost savings over hospital-based procedures, near-perfect patient satisfaction, and rapid recovery times. With Medicare poised to shift millions of procedures outpatient by 2026, Oath is betting on a new model for complex surgery: high-tech, value-based, and surgeon-led.
New research presented at DDW 2025 suggests that biomarker-guided therapy could help predict which IBD patients will respond best to drugs like infliximab. In a German phase 3 trial, patients whose doctors used personalized biomarker reports achieved higher remission rates (55% vs 27%) and fewer failed therapies over one year. Experts say this integrated biomarker approach moves care closer to true precision medicine, though more studies are needed before it becomes standard practice.
Conexiant will take over publishing GI & Hepatology News, the flagship clinical and policy publication of the American Gastroenterological Association, starting Jan. 1, 2026. The partnership aims to expand the reach, quality, and impact of the news source for gastroenterologists and hepatologists worldwide. AGA leaders see this collaboration as a key step in scaling educational impact and strengthening connections across the field.
Doximity’s 2025 Physician Compensation Report shows only modest pay growth but widening disparities across gender, pediatric vs. adult specialties, and practice settings. Gastroenterologists averaged $537,870, ranking 13th overall. Despite rising burnout and overwork, most physicians would still choose the profession—though many consider leaving or scaling back. The findings highlight systemic inequities, with AGA leaders calling for stronger gender equity initiatives.
At least 47% of physicians were employed by or affiliated with hospital systems in 2024, up from around 30% in 2012, according to a new Government Accountability Office report. Here are five GI trends from the report: 1. Private equity roll-ups are shaping GI. One firm grew a GI network from 110 to 400+ sites in four years, reaching a $2.2 billion valuation before physicians bought back ownership with new PE support. 2. Market concentration is rising. In some metro areas, private equity firms employ over 30% of gastroenterologists, often with a single firm dominating local market share.
A new analysis has revealed striking cost disparities tied to physician practice affiliation. For the same high-volume procedures across cardiology, gastroenterology, orthopedics, and urology, hospital outpatient departments emerged as the most expensive sites of care—sometimes exceeding costs in ambulatory surgery centers or physician offices by over 1,000%. Independent and private equity-affiliated physicians were far more likely to treat patients in lower-cost settings, while hospital-based doctors consistently gravitated toward higher-cost environments.
Omada Health has introduced Meal Map, a nutrient-categorization tool that blends AI feedback with human care support to help patients build sustainable eating habits. Unlike restrictive diets, the platform emphasizes nutrient density — boosting immunity, energy, digestive health, and reducing risks of cardiovascular disease, diabetes, and cancer. A pilot with 1,000+ members showed higher engagement, with instant meal analysis and weekly nutrition progress reports. Positioned within Omada’s “Nutritional Intelligence” suite, it aligns with the surge in GLP-1 use and demand for long-term, food-freedom strategies.
This week’s OncoDaily GI curation spans some of the most exciting fronts in gastrointestinal oncology: Each post features insights from global leaders — from Francesc Balaguer to Catherine Alix-Panabières — offering a window into how prevention, precision medicine, and equity are reshaping GI cancer care.